Don't judge a book by its cover: The role of statins in liver cancer

N Piekuś-Słomka, LP Mocan, R Shkreli, C Grapă… - Cancers, 2023 - mdpi.com
Simple Summary Statins are a group of remedies developed to treat lipid disorders
associated with cardiovascular diseases. Thanks to their high efficiency, they are the primary …

Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic

H Suzuki, N Fujiwara, AG Singal, TF Baumert… - Hepatology, 2024 - journals.lww.com
Preventive interventions are expected to substantially improve the prognosis of patients with
primary liver cancer, predominantly hepatocellular carcinoma (HCC) and …

Dietary intake, obesity, and physical activity in association with biliary tract cancer risk: Results from meta‐analyses of individual‐level data from prospective cohort …

V Gunchick, W Wen, G Jia, LR Roberts… - … Journal of Cancer, 2024 - Wiley Online Library
Biliary tract cancer (BTC) is a rare and aggressive malignancy with increasing incidence.
Most BTC cases are diagnosed with metastatic disease which carries a 5‐year survival rate …

[HTML][HTML] Interplay of Cardiometabolic Syndrome and Biliary Tract Cancer: A Comprehensive Analysis with Gender-Specific Insights

V Di Stasi, A Contaldo, LI Birtolo, E Shahini - Cancers, 2024 - mdpi.com
Simple Summary Metabolic syndrome (MetS), metabolic dysfunction-associated steatotic
liver disease (MASLD), and diabetes are all linked to Cholangiocarcinoma (CCA) in various …

Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study

XX Zhu, JH Li, P Fang, XF Qu, LJ Liang, JM Lai, XY Yin - BMC cancer, 2023 - Springer
Background Hypertension is a risk factor for cholangiocarcinoma (CCA). The effect of anti-
hypertensive drugs on the prognosis of CCA is not clear. Methods This is a retrospective …